PBRT associated with a lower opioid pain requirement and a lower rate of gastrostomy tube dependence
02/02/2016
/
Publications
/
Chemotherapy
IMRT
Chemotherapy
A matched analysis compared PBRT and IMRT for nasopharynx and paranasal sinus cancers with concurrent chemotherapy, reported that PBRT was associated with a...
Neurocognitive and psychological functioning of pediatric brain tumor patients undergoing proton beam therapy for three different tumor types.
11/11/2021
/
Publications
This is a prospective study by the group from National Cancer Center, Korea, examining the neuropsychological functioning of patients with varying types of BTs...
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
11/11/2019
/
Publications
Published in the Red Journal, this study identified patients who benefit most from PBT in terms of predicted 30-year absolute mortality risks (AMR30) from...
Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation.
11/11/2021
/
Publications
/
IMPT
Treatment and acute toxicity data of 17 chordoma and 3 chondrosarcoma patients treated with IMPT were retrospectively evaluated in this study. This study found...
Assessment of Radiation-Induced Optic Neuropathy in a Multi-Institutional Cohort of Chordoma and Chondrosarcoma Patients Treated with Proton Therapy
10/10/2021
/
Publications
Radiation-induced optic neuropathy (RION) is a rare side effect following radiation therapy. A multi-institutional cohort including 289 skull-base cancer...
CT-on-Rails Versus In-Room CBCT for Online Daily Adaptive Proton Therapy of Head-and-Neck Cancers
11/11/2021
/
Publications
/
Dosimetry
This study compared the efficacy of CT-on-rails versus in-room CBCT for daily adaptive proton therapy. CT-on-rails provides high precision accuracies, but the...
A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
12/12/2021
/
Publications
/
IMPT
VMAT
A cohort of tonsil and salivary gland cancer patients who received ipsilateral curative-intent radiotherapy delivered by IMPT or VMAT were reviewed including...
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy.
06/11/2021
/
Publications
/
Hypofractionation
Toxicity
IMPT
This a study protocol that details a phase 1 trial investigating a new approach using image-guided proton therapy for dose escalation treatments for selected...
Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.
10/10/2021
/
Publications
/
Dosimetry
Reirradiation
Motion Management
In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...
Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer.
11/11/2021
/
Publications
/
Chemotherapy
This study reported outcomes of 25 patients with limited-stage small cell lung cancer treated with combined proton and carbon-ion radiotherapy. Proton and...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.